DOCHERTY JOHN MARTIN 4
4 · Lexaria Bioscience Corp. · Filed May 31, 2018
Insider Transaction Report
Form 4
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
- Award
Stock Options
2018-05-31$1.53/sh+400,000$612,000→ 1,250,000 totalExercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (400,000 underlying)
Holdings
- 1,312,000(indirect: Private holding company)
Common Shares
- 550,000
Stock Options
Exercise: $0.09From: 2015-03-26Exp: 2020-03-26→ Common Shares (550,000 underlying) - 850,000
Stock Options
Exercise: $0.11From: 2016-04-15Exp: 2021-04-15→ Common Shares (300,000 underlying)